Business
Target To Report Earnings On Wednesday
(Getty Images)

Target’s shares plunge 21% after huge earnings miss

Target made a bet on courting lower-income consumers. So far, it hasn’t worked.

Target severely missed earnings expectations on Wednesday, spooking investors who are now sending the retailer’s stock price toward its worst daily drop in over two years and its third-worst day in the stock market ever.

The company’s share price tanked 21% on Wednesday morning after it reported a sales decline, lower profit, and a stockpile of unsold inventory. The last time its stock took a hit bigger than that was in May 2022, when it dropped 25%. Wednesday’s decline would erase more than $15 billion of market capitalization.

Target slashed its forecast for full-year earnings per share to between $8.30 and $8.90, down from its prior range of $9 to $9.70. You know it’s not good when a company’s new best-case scenario is lower than its previous worst-case scenario.

Target’s earnings miss came after Walmart, seen as an industry bellwether, exceeded Wall Street’s expectations on Tuesday.

Walmart reported lower transactions but with larger average ticket sizes. Target, which announced earlier this year that it was lowering prices on thousands of items, appeared to be taking the opposite approach — banking on customers spending less each time but driving more traffic. In its most recent quarter, though, the number of transactions and ticket sizes both declined.

Analysts at Telsey Advisory Group said in a Wednesday-morning research note that Walmart might be stealing market share from Target’s core customers.

“We understand the challenging macro environment and select cost pressures, but Target may be losing share among its middle- to upper-income consumers to retailers like Amazon, Costco, and Walmart,” the analysts wrote.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.